Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)
Year: 2016
Type: article
Study design: Clinical Trial
Source: Targeted Oncology
Authors: Akihito Tsuji, Yu Sunakawa, Wataru Ichikawa, Masato Nakamura, Mitsugu Kochi, Tadamichi Denda, Tatsuro Yamaguchi, Ken Shimada, Akinori Takagane, Satoshi Tani, Masahito Kotaka, Hidekazu Kuramochi, Kaoru Furushima, Junichi Koike, Yutaka Yonemura, Masahiro Takeuchi, Masashi Fujii, Toshifusa Nakajima
Institutions: Kagawa University, Kagawa University Hospital, SHOWA Medical University Northern Yokohama Hospital, SHOWA Medical University Fujigaoka Hospital, Aizawa Hospital, Nihon University, Chiba Cancer Center, Tokyo Metropolitan Komagome Hospital, SHOWA Medical University Koto Toyosu Hospital, Hakodate Goryoukaku Hospital, Konan Medical Center, Sano Hospital, Tokyo Women's Medical University Yachiyo Medical Center, NTT (Japan), NTT Medical Center, Toho University, Kishiwada Tokushukai Hospital, Kitasato University, Japan Clinical Cancer Research Organization
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2420055265